Catherine Van Dongen
Hepatology · 2023
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Catherine Van Dongen trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- W. Viechtbauer (in Statistics and Probability)
Papers from Catherine Van Dongen's perspective
Ordered by how strongly the researchers Catherine Van Dongen trusts endorse each paper. Same corpus, a different order for every researcher.
- Improved tests for a random effects meta‐regression with a single covariate (Statistics in Medicine)
- Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data (International Journal of Evidence-Based Healthcare)
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (Hepatology)
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (Hepatology)
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. (The Lancet Gastroenterology and Hepatology)
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. (Journal of Hepatology)
- Conducting Meta-Analyses in R with the metafor Package
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. (The Lancet Gastroenterology and Hepatology)
- Non-alcoholic fatty liver disease (The Lancet)
- Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025 (Scientific Reports)